°í·Á´ëÇб³ ¾È¾Ïº´¿ø(¿øÀå ¹ÚÁ¾ÈÆ)Àº 26ÀÏ ¿ÀÀü 10½Ã ÀÇ°ú´ëÇÐ 2Ãþ À¯±¤»çȦ¿¡¼ ¡®ÀÓ»ó½ÃÇè±Û·Î¹ú¼±µµ¼¾ÅÍ ½ÉÆ÷Áö¾ö¡¯À» °³ÃÖÇß´Ù.
À̹ø ½ÉÆ÷Áö¾öÀº °í·Á´ëÇб³ ¾È¾Ïº´¿ø ÀÓ»ó½ÃÇè¼¾ÅÍ(¼¾ÅÍÀå ±è½Å°ï) ÁÖ°üÀ¸·Î °³ÃֵǾúÀ¸¸ç ¡®Global Trends in Clinical Trials and Translational Research¡¯¸¦ ÁÖÁ¦·Î ÁøÇàµÆ´Ù.
Keynote Speech ¿¬ÀÚ·Î (Àç)Çѱ¹ÀÓ»ó½ÃÇè»ê¾÷º»ºÎ Áöµ¿Çö ÀÌ»çÀåÀÌ ÃÊûµÇ¾úÀ¸¸ç, ¼¼°èÀû ¼®ÇÐÀÎ Dr. Mary L. Nora Disis¸¦ ºñ·ÔÇÏ¿© ÀÓ»ó½ÃÇèÀ» ¼±µµÇÏ´Â ±¹³»¿Ü ¿¬±¸ÀÚ¸¦ ÃÊûÇØ Áß°³¿¬±¸ ¼º°ø»ç·Ê¸¦ ¹ßÇ¥ÇÏ´Â µî ÃֽŠ¿¬±¸ µ¿ÇâÀ» ÆľÇÇÏ°í ±¹Á¦Çù·ÂÀ» µµ¸ðÇÏ°íÀÚ ¸¶·ÃµÇ¾ú´Ù.
À̳¯ ½ÉÆ÷Áö¾ö¿¡´Â ¡ã Immunologic Monitoring In Immunooncolgy(Dr. Mary L. Nora Disis, ¿ö½ÌÅÏ´ëÇб³) ¡ã A clinician¡¯s real story from bench to bedside(È«¼øÁØ, °í·Á´ëÇб³¾È¾Ïº´¿ø) ¡ã P-HIS, as a clinical trial platform(À±½ÂÁÖ, °í·Á´ëÇб³¾È¾Ïº´¿ø) ¡ã Development of 3-D organoid cultures for the study of tumorigenesis in mouse and human(ÀÌÇö¼÷, ¼¿ï´ëÇб³) ¡ã Experience in acquiring MFDS approval for the first AI medical device(±èÇöÁØ, VUNO) ¡ã Utilization of Big Data in Planning Phase of Clinical Trials(±è¹Î°É, ÀüºÏ´ëÇб³) ¡ã Registry-based researches and randomized clinical trial(±è¹üÁØ, ºÐ´ç¼¿ï´ëº´¿ø) ¡ã Clinical research utilizing of the healthcare Big Data in Korea(ÃÖÀμ±, NECA) µî ´Ù¾çÇÑ °¿¬ÀÌ ÀÌ·ïÁ³´Ù.
ÇÑÆí, °í·Á´ëÇб³ ¾È¾Ïº´¿ø ÀÓ»ó½ÃÇè¼¾ÅÍ´Â 2014³â 11¿ù º¸°Çº¹ÁöºÎ·ÎºÎÅÍ ÀÓ»ó½ÃÇè±Û·Î¹ú¼±µµ¼¾ÅÍ·Î ÁöÁ¤µÇ¾î ±¹³» À¯¼öÀÇ 5°³ º´¿øÀ¸·Î ÀÌ·ïÁø ¡®PARTNERSÄÁ¼Ò½Ã¾ö¡¯°ú ÇÔ²² ±¹°¡°úÁ¦¸¦ ½ÃÇàÇÏ´Â µî ¿Õ¼ºÇÑ È°µ¿À» ÆîÄ¡°í ÀÖ´Ù.